This webinar discusses a “Reproducible Derivation of Integration-Free Human iPS Cells using mRNA” as presented by Stemgent Senior Scientist Brad Hamilton at ISSCR 2011. This presentation will highlight the internal validation of a new line of Stemgent mRNA reprogramming products for the reliable and consistent generation of integration-free human iPS cells.
Between research advances and legal setbacks, scientists in the stem cell community are surely suffering from collective whiplash these days. First, the good news. The field achieved a milestone in October as...
The landscape of cell culture looks much more vibrant these days. Gone is the bland horizon of a few traditional formulations. Now that scene most resembles a multicolored tableau of options that suit a multitude of uses and cell types. While classic reagents and tools still pervade laboratory shelves, the newest products provide...
Removing cells from an adult, changing them into another cell type, and reintroducing them back into the adult who made them (with healing consequences)—it sounds like the plot of a medical sci-fi thriller, but...
Protein kinases are enzymes with great power. Up to 30% of human proteins may be regulated by kinase activity. In fact, kinases regulate most intracellular pathways, especially...
We demonstrate the protocol for the generation of induced pluripotent stem cells from human somatic cells using lentivirus-mediated delivery of the human factors Oct4, Sox2, Nanog, and Lin28. Pluripotency was confirmed by morphology and the presence of embryonic stem (ES) cell-specific markers.
It’s an exciting time for human embryonic stem cell (hESC) researchers. Unfortunately, hESC research isn’t easy—in fact, it is anything but; hESCs are the double black diamond runs of cell biology.